GLP‑1 Atlas

Injection sites, and why rotation matters

Three approved areas, one simple rule, and a failure mode that quietly reduces how much drug you absorb.

The short version

  • Approved sites are the abdomen, thigh and upper arm — all subcutaneous, not muscle.
  • Rotate. Repeatedly injecting the same spot causes lipohypertrophy: firm fatty lumps that absorb drug unpredictably.
  • Stay about 5 cm away from the navel and away from any area that is bruised, tender, scarred or hardened.
  • Absorption differences between the approved sites are not clinically significant for weekly products — consistency matters more than which site.

Injection technique gets less attention than dose, and for the most part it deserves less. But there is one failure mode worth understanding, because it develops slowly, feels like nothing, and quietly undermines the treatment.

The three sites

  • Abdomen. The most used. Avoid a circle of roughly 5 cm around the navel, where tissue is tougher and absorption less consistent.
  • Front of the thigh. The upper outer area. Easy to reach and easy to see.
  • Back of the upper arm. Effective but awkward to do for yourself; more practical if someone else administers it.

All three are subcutaneous — into the fat layer beneath the skin, not into muscle. Modern pen needles are short enough that this happens naturally at a 90-degree angle for most people.

What happens without rotation

Repeated injection into the same small area causes fat cells there to enlarge and the tissue to thicken. The result is lipohypertrophy: a firm, often slightly raised patch that is usually painless.

Painless is the problem. Because the area has reduced sensation, it becomes the most comfortable place to inject, so people preferentially return to it — which makes it worse. And drug delivered into that tissue is absorbed erratically. Some doses go in fully, some do not.

Erratic absorption looks like a treatment that stopped working. If results plateau without an obvious cause, feeling your usual injection area for firm patches is worth doing before concluding the dose is inadequate. A clinician can confirm — and the tissue usually recovers if that area is rested for several months.

A rotation that people actually follow

Elaborate schemes fail because nobody remembers them. What works is a rule simple enough to run on autopilot:

  • Divide each area into quadrants.
  • Move to the next quadrant every injection, in a fixed direction.
  • Move to the next area each month.
  • Keep successive injections at least 2–3 cm apart within an area.

With a weekly injection this means any single spot is revisited only after a long interval — enough for the tissue to recover fully.

Practical points

  • A new needle every time. Reused needles are blunt, which hurts more and damages tissue.
  • Room temperature stings less. Taking the pen out ten to fifteen minutes ahead makes a noticeable difference.
  • Do not rub afterwards. Light pressure if needed; rubbing can affect how the dose disperses.
  • Skip damaged skin. Bruises, scars, moles, tattoos and inflamed areas absorb unpredictably.
  • Mild local redness is normal. Spreading redness, warmth or pain that worsens over days is not — that needs looking at.

Storage, briefly. Unopened pens live in the fridge. Once in use, most products tolerate room temperature for a defined number of days — the number differs by product, and it is on your leaflet. Never freeze a pen; a frozen pen is discarded, not thawed.

A rotation you will actually keep

Elaborate schemes fail because nobody remembers them. What survives contact with a real week is a rule simple enough to run without thinking:

  • Divide each area into quadrants — four in the abdomen, two in each thigh, two in each upper arm.
  • Move to the next quadrant every injection, always in the same direction.
  • Move to the next area each month.
  • Keep successive injections at least 2–3 cm apart within an area.

With a weekly injection this means any single spot is revisited only after a long interval — comfortably enough for tissue to recover fully. With a daily product the same principle applies at four times the pace, which is why writing it down matters more there.

A simple map kept where you inject beats memory, and beats it by a wide margin if someone else is administering the injection. The person receiving it cannot see the pattern; the person giving it will not recall it.

How to check for lipohypertrophy

You are looking for a change in texture rather than in appearance, which is why it goes unnoticed for so long. With the flat of your fingers, press gently across the areas you use most and feel for firmness — a patch that is denser or slightly raised compared with the tissue around it, usually without tenderness.

Compare one side against the other; asymmetry is easier to detect than absolute change. Do this every couple of months rather than obsessively, and do it before concluding that a plateau means your dose is inadequate.

If you find one, the treatment is simply to stop using that area. Tissue generally recovers over several months of rest, and a clinician can confirm what you are feeling.

Storage, temperature and the sting

A cold pen stings more. Taking it out of the fridge ten to fifteen minutes before injecting is the single easiest way to make the routine less unpleasant, and it is the step most often skipped by people in a hurry.

Beyond comfort, check the liquid before every dose: clear and colourless, no particles, no frosting. Anything else means ask a pharmacist rather than inject.

Bruising, bleeding and small mishaps

  • A small bleed. You caught a capillary. Light pressure, and choose a different spot next time.
  • A bruise. Common and harmless. Avoid that area until it has resolved.
  • A drop of liquid at the skin. Not a meaningful loss. Holding the needle in place longer before withdrawing reduces it. Never re-inject to compensate.
  • Sharp pain. Usually a blunt or reused needle, or a site too close to muscle. It should not be sharp.
  • Spreading redness, warmth, or pain worsening over days. Not part of the picture — that needs looking at.

Sources

  1. Instructions for Use accompanying Ozempic®, Wegovy®, Mounjaro®, Zepbound®, Saxenda® and Trulicity® pens.
  2. Clinical guidance on injection technique and lipohypertrophy prevention in subcutaneous therapy.

Related

  • Side effects, week by week — Nausea on a GLP-1 is not random. It follows the dose ladder on a schedule you can predict — and predicting it is most of what makes it manageable.
  • Constipation, and what actually helps — The side effect most likely to persist rather than fade — and the one most responsive to three unglamorous changes.

Which medicine you are on

Everything above applies across the class, because it comes from a shared mechanism. The numbers that differ — dose ladders, missed-dose windows, in-use storage periods, half-lives — differ by product, sometimes substantially. Each medicine has its own reference here:

Ozempic · Wegovy · Mounjaro · Zepbound · Rybelsus · Saxenda · Victoza · Trulicity · all medicines

How this page is sourced. Figures come from manufacturers' approved labelling and from published clinical and pharmacokinetic literature. Regional labels differ, sometimes materially — where a number matters, the leaflet in your own box outranks anything written here. This site is not written or medically reviewed by clinicians, and we say so rather than implying otherwise; our editorial standards set out what that means and how corrections work.